Marker Therapeutics, Inc. (MRKR) Insider Trading & SEC Filings
Last SEC filing
Marker Therapeutics, Inc. (MRKR) - no SEC Form 4 insider filings recorded in the last 90 days. InsiderAlpha tracks every MRKR SEC filing - Form 4, Form 144, and 8-K - in real time, including Rule 10b5-1 plan detection.
About Marker Therapeutics, Inc. (MRKR)
Marker Therapeutics, Inc. trades under the ticker MRKR. InsiderAlpha tracks 7 primary SEC Form 4 filings from 6 reporting insiders for MRKR since 2024, sourced directly from SEC EDGAR.
| SEC CIK | 0001094038 |
|---|
Recent MRKR Insider Transactions (Form 4)
| Date | Insider | Role | Transaction | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| New Enterprise Associates 16, L.P. | Insider | P - Open-market purchase | 554.2K | $3.20 | $1.77M | SEC | |
| Steve Elms | Director | P - Open-market purchase | 11.1K | $3.20 | $35K | SEC |
All transactions sourced from SEC EDGAR Form 4 filings for Marker Therapeutics, Inc. (MRKR). Updated in real time as new filings are submitted to the SEC.
Recent MRKR Form 8-K Material Events
- - Item 5.03, 5.07, 9.01 [SEC]
- - Item 2.02, 9.01 · Earnings · neutral [SEC]
Marker Therapeutics reported financial results for the year ended December 31, 2025, along with other recent corporate updates on March 18, 2026. The filing provides standard annual financial reporting without explicit beat/miss language or forward guidance changes.
Recent Insider Filings
- - Norman David Eansor (Director)
- - Steve Elms (Director)
- - Katharine Knobil (Director)
- - Kathryn Penkus Corzo (Director)
- - Juan Vera (Chief Executive Officer)
Form 4 Transaction Code Reference
SEC Form 4 transactions are reported with a one-letter code indicating the type of transaction. Common codes you'll see in MRKR insider filings:
| P | Open-market purchase by the insider |
|---|---|
| S | Open-market sale by the insider |
| A | Grant, award, or other acquisition from the issuer |
| M | Exercise or conversion of derivative security (e.g. options) |
| F | Payment of exercise price or tax liability via share withholding |
| G | Bona-fide gift of securities |
| D | Disposition to the issuer (e.g. share buyback participation) |
| J | Other acquisition or disposition |
| X | Exercise of in-the-money or at-the-money derivative security |
| C | Conversion of derivative security |
| V | Transaction voluntarily reported earlier than required |
MRKR Insider Trading - FAQ
- What is the latest insider trade for MRKR?
- Marker Therapeutics, Inc. (MRKR) had 0 insider filings in the last 90 days, with the most recent on 2025-11-19. InsiderAlpha tracks every Form 4, Form 144, and 8-K filing in real time.
- How many insiders are buying MRKR stock?
- 0 insider purchases of MRKR were filed in the last 90 days.
- How many insiders are selling MRKR stock?
- 0 insider sales of MRKR were filed in the last 90 days.
- Where can I see MRKR SEC filings (Form 4, 10-K, 10-Q, 8-K)?
- This page tracks MRKR Form 4 insider transactions, Form 144 sale notices, and 8-K material event disclosures in one timeline. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
More Companies with Insider Activity
Other companies in the InsiderAlpha index with a significant SEC Form 4 insider-trading footprint:
- $MRLN Bleichroeder Acquisition Corp. I
- $MRO MARATHON OIL CORP
- $MSBT Morgan Stanley Bitcoin Trust
- $MSS Maison Solutions Inc.
- $MTAKU Market Technology Acquisition Corp
- $MTAL Metals Acquisition Corp. II
- $MTEN Mingteng International Corp Inc.
- $MTNE CH4 Natural Solutions Corp
- $MTNOF MTN GROUP LTD/ADR
- $MUA BLACKROCK MUNIASSETS FUND, INC.
Learn More
- What is SEC Form 4?
- How to read insider buying signals
- Rule 10b5-1 trading plans explained
- The cluster buying signal
Open the live MRKR dashboard on InsiderAlpha for real-time alerts, charting, and full historical filing search.